Health data is everywhere, making new demands on analytical tools and service models
Medical health enters the era of big data
In many countries, health care data has become an important part of national public utilities, investing a lot of money (similar to the construction of American highways around 1950). Patients, health care providers, and health departments currently use these data to improve diagnosis and treatment and increase productivity in the healthcare industry . Pharmaceutical companies are working hard with patients and health systems to develop better drugs through data mining to bring these products to market faster and to guide pricing based on actual results.
1. Health big data becomes a new economic indicator, dismantling traditional R&D barriers
The health system recognizes the value of existing and new data (such as electronic medical records, patient-supplied data) and has enacted management methods for data acquisition and data sharing, establishing a data analysis collaboration platform and changing the way medical care is based on the results of data analysis. ;
The use of health data has become a new indicator of national economic development;
Pharmaceutical companies are attracting various partners (payment systems, hospital systems) while attracting data talents in various ways to attract data talents (data management, analysis), in order to develop the entire pricing Make the most of big data in the value chain. The role of data has far exceeded the boundaries of traditional research, product development and commercial use.
New data-driven market competitors have dismantled traditional R&D barriers, focusing on data and final output, which is quite different from previous approaches to research only;
Genetic testing is considered feasible.
2. Personal health data is widely used by professionals
The public recognizes the benefits of making reasonable use of personal health data.
The country's large investment in IT and health data infrastructure makes data acquisition easier, while also protecting the privacy of user data and regulating the use of user data.
A constantly improving regulatory environment and high-quality user data (collected from fitness tracking devices and real-time monitoring devices) gives consumers more say and gives consumers more confidence in how others use their data.
Healthcare professionals can get patient data in real time and use analysis tools to compare data to help with daily diagnosis.
Pharmaceutical companies are the more trusted partners in the entire health system, and they have a proven track record of collaboration in diagnostics, data analysis, private and public health services.
Pharmaceutical companies have found ways to process their data to avoid the inconvenience caused by imperfect health systems.
We can see such a scene in 2020.
1. Fragment of the annual report of the Independent Data Service Center: In the fifth year of the data center, the alliance between pharmaceutical companies, data management and analysis companies, and primary and secondary health systems has produced improved outcomes.
It answers basic questions about medical service design and treatment options (eg, the role of medical guidance in behavioral change) and insight into the timing of the use of specific drugs for specific populations.
The current focus of the data center is to guide the development of new drugs based on a large number of patient biomarkers and genomic data.
2. Big data is fully applied to all stages of diagnosis and treatment: Nadia, who is nearly 40 years old, suffers from severe asthma. The primary care doctor advised her to go to the hospital to seek the help of a specialist. The health data collected by watches and smartphones (Nadia regularly provides this data to doctors) indicates that her condition has deteriorated, which is a concern for doctors. The doctor also learned about the extent and type of air pollution that caused her to develop through a weather app used by Nadia.
Jiangsu Tiera Biotechnology Co., Ltd , https://www.tierabio.com